Correlation Between Cipher Pharmaceuticals and HLS Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cipher Pharmaceuticals and HLS Therapeutics, you can compare the effects of market volatilities on Cipher Pharmaceuticals and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and HLS Therapeutics.

Diversification Opportunities for Cipher Pharmaceuticals and HLS Therapeutics

-0.57

Correlation Coefficient

Cipher Pharmaceuticals  HLS Therapeutics

Excellent diversification

The 3 months correlation between Cipher and HLS is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and HLS Therapeutics go up and down completely randomly.

Pair Corralation between Cipher Pharmaceuticals and HLS Therapeutics

Assuming the 90 days trading horizon Cipher Pharmaceuticals is expected to under-perform the HLS Therapeutics. In addition to that, Cipher Pharmaceuticals is 1.27 times more volatile than HLS Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. HLS Therapeutics is currently generating about 0.13 per unit of volatility. If you would invest  436.00  in HLS Therapeutics on May 1, 2025 and sell it today you would earn a total of  62.00  from holding HLS Therapeutics or generate 14.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.41%
Values	Daily Returns

Cipher Pharmaceuticals  vs.  HLS Therapeutics

Cipher Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

HLS Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, HLS Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cipher Pharmaceuticals and HLS Therapeutics

The main advantage of trading using opposite Cipher Pharmaceuticals and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.

The idea behind Cipher Pharmaceuticals and HLS Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.